Virax Biolabs Group (NASDAQ: VRAX) reported Q1 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Virax Biolabs Group earnings for the quarter were N/A. In the same quarter last year, Virax Biolabs Group's earnings per share (EPS) was N/A.
As of Q3 2023, Virax Biolabs Group's earnings has grown year over year. Virax Biolabs Group's earnings in the past year totalled -$5.46 million.
What was VRAX's revenue last quarter?
Virax Biolabs Group (NASDAQ: VRAX) reported Q1 2023 revenue of N/A up N/A year over year. In the same quarter last year, Virax Biolabs Group's revenue was N/A.
What was VRAX's revenue growth in the past year?
As of Q3 2023, Virax Biolabs Group's revenue has grown null year over year. Virax Biolabs Group's revenue in the past year totalled $8.56 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.